Author

Michal Mahdal

Masaryk UniversityORCID 0000-0002-2136-9136Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Dušan ZoufalýiD· 1 shared Iva Staniczková ZamboiD· 1 shared Jakub NeradiliD· 1 shared Jan SkodaiD· 1 shared Olga PiskarevaiD· 1 shared Petr ChlapekiD· 1 shared Veronika KnechtovaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Dušan ZoufalýORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Receptor tyrosine kinase inhibitors trametinib and axitinib effectively target the neoplastic component of giant cell tumor of bone in vitro

Veronika Knechtova, Michal Mahdal, Iva Staniczková Zambo, Dušan Zoufalý, Olga Piskareva, Petr Chlapek, Jan Skoda, Jakub Neradil

This study identifies trametinib and axitinib as effective inhibitors of GCTB stromal cells in vitro, showing selective activity against tumor cells compared to healthy controls.

bioRxiv · Oct 6, 2026 · PreprintCancer Biology